Nasty Viruses, Costly Plasmids, Population Dynamics, and the Conditions for Establishing and Maintaining CRISPR-Mediated Adaptive Immunity in Bacteria by Levin, Bruce R.
Nasty Viruses, Costly Plasmids, Population Dynamics,
and the Conditions for Establishing and Maintaining
CRISPR-Mediated Adaptive Immunity in Bacteria
Bruce R. Levin*
Department of Biology, Emory University, Atlanta, Georgia, United States of America
Abstract
Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR) abound in the genomes of almost all archaebacteria
and nearly half the eubacteria sequenced. Through a genetic interference mechanism, bacteria with CRISPR regions carrying
copies of the DNA of previously encountered phage and plasmids abort the replication of phage and plasmids with these
sequences. Thus it would seem that protection against infecting phage and plasmids is the selection pressure responsible
for establishing and maintaining CRISPR in bacterial populations. But is it? To address this question and provide a
framework and hypotheses for the experimental study of the ecology and evolution of CRISPR, I use mathematical models
of the population dynamics of CRISPR-encoding bacteria with lytic phage and conjugative plasmids. The results of the
numerical (computer simulation) analysis of the properties of these models with parameters in the ranges estimated for
Escherichia coli and its phage and conjugative plasmids indicate: (1) In the presence of lytic phage there are broad
conditions where bacteria with CRISPR-mediated immunity will have an advantage in competition with non-CRISPR bacteria
with otherwise higher Malthusian fitness. (2) These conditions for the existence of CRISPR are narrower when there is
envelope resistance to the phage. (3) While there are situations where CRISPR-mediated immunity can provide bacteria an
advantage in competition with higher Malthusian fitness bacteria bearing deleterious conjugative plasmids, the conditions
for this to obtain are relatively narrow and the intensity of selection favoring CRISPR weak. The parameters of these models
can be independently estimated, the assumption behind their construction validated, and the hypotheses generated from
the analysis of their properties tested in experimental populations of bacteria with lytic phage and conjugative plasmids. I
suggest protocols for estimating these parameters and outline the design of experiments to evaluate the validity of these
models and test these hypotheses.
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Introduction
For many species of bacteria, adaptive evolution is through the
expression of chromosomal and extrachromosomal (plasmid- and
prophage - borne) genes or clusters of genes (pathogenicity and
nicer islands) acquired by horizontal gene transfer (HGT) from the
same or even quite distant species [1,2]. Thus, on first
consideration it may seem that bacteria and their accessory
genetic elements would have mechanism to promote the
acquisition, incorporation and expression of genes from without.
And, indeed there are mechanisms like integrons [3–7] that
appear to have that function. On the other side, DNA acquired
from external sources may be deleterious. This is certainly the case
when that DNA is borne on lytic bacteriophage, but also for
plasmids that engender fitness costs [8,9] or chromosomal DNA
from the wrong source [10,11]. To deal with these contingencies,
it would seem that bacteria would have mechanisms to protect
themselves against infection by deleterious foreign DNA [12]. And
indeed there are systems like restriction-modification (restriction
endonucleases) which appear to have that role [13,14].
The most recently discovered mechanism postulated to provide
bacteria immunity to infectious genetic elements are Clustered
Regularly Interspaced Short Palindromic Repeats (CRISPR). For
recent reviews see [15,16]. CRISPR is particularly intriguing
because of its ubiquity, appearing in ,90% and ,40% of archaeal
and eubacterial sequenced genomes, respectively, and because of
the adaptive mechanism by which it provides immunity to
infections by a virtually indefinite diversity of bacteriophage and
plasmids. DNA from infecting phage and plasmids is incorporated
into the CRISPR array. Through a yet to be fully elucidated
mechanism, bacteria abort the replication of infecting phage [17]
or the establishment of conjugative plasmids [18] bearing copies of
the DNA incorporated into their CRISPR arrays, also see [19].
Further support for CRISPR being an adaptive immune system
that is maintained because it protects bacteria from infection with
phage comes from studies of the community ecology of bacteria
and phage; DNA in the CRISPR regions of the bacteria from
those communities corresponds to that in the co-existing phage
[20–23]. For an intriguing perspective on CRISPR as a witness to
the coevolutionary history of bacteria and phage, see [24].
PLoS Genetics | www.plosgenetics.org 1 October 2010 | Volume 6 | Issue 10 | e1001171CRISPR-mediated immunity has been likened to a Lamarckian
mechanism [25], because the selection pressure, the infecting
phage and plasmids, determine the genotype. This analogy
however does not account for the evolution and maintenance of
the machinery responsible for taking up the infecting phage and
plasmid DNA and the mechanism employed to prevent the
replication or establishment of infecting genetic elements with
those sequences. Under what conditions will adaptive immunity to
phage and plasmid infection be the selection pressure responsible
for establishing and maintaining CRISPR-mediated immunity in
populations of archeae and bacteria? What about other mecha-
nisms of resistance, like structural modification blocking phage
adsorption (envelope resistance) and restriction-modification?
How do these mechanisms interact with CRISPR – acquired
immunity and contribute to its establishment and maintenance?
To address these questions and provide a framework and
hypotheses for their study experimentally, I use mathematical
models of the population dynamics of bacteria, phage and plasmids
to explore the conditions under which a CRISPR–like adaptive
immune mechanism will provide bacteria a selective advantage in
competition with bacteria without this immune system. The results
of the numerical analysis of the properties of these models suggest
that with bacterial replication and phage infection parameters in
realisticranges,therearebroadbutnot universalconditionswherea
CRISPR–like adaptive immune system can be favored and will be
maintained in populations of bacteria confronted with lytic phage.
While this model predicts conditions where CRISPR-mediated
immunity will be favored when bacteria compete with populations
bearing conjugative plasmids, these conditions are relatively
restrictive. The parameters of these models can be independently
estimated, the validity of the assumptions behind their construction
andthehypotheses generated from the analysisofthepropertiescan
be tested in experimental populations of bacteria with lytic phage
and conjugative plasmids. Procedures for doing these experiments
are outlined and their potential outcomes described and/or
speculated upon. Also discussed are the broader implications of
CRISR-mediated adaptive immunity to the population and
evolutionary biology and ecology of bacteria and phage.
Model
Bacterial growth and population maintenance
Both the lytic phage and conjugative plasmid models used here
assume a chemostat-like habitat. The bacteria grow at a rate that is
a monotonically increasing function of the concentration of a
limiting resource, R mg/ml [26].
yi(R)~Vi
R
Rzk

where Vi hr
21 is the maximum growth rate of the i
th strain of
bacteria and k the concentration of the resource when the growth
rate is half its maximum value (the ‘‘Monod constant’’). The
populations are maintained in a vessel of unit volume, (1ml) into
which medium containing the limiting resource from a reservoir
where it is maintained at a concentration A mg/ml flows in at a
rate w per hour. Excess resource and wastes are removed from the
vessel at the same rate. As in [27], the rate of uptake of the
resource by the bacteria is proportional to the density, the resource
concentration-dependent growth rates of the different populations
of bacteria and a conversion efficiency parameter, e mg/per cell.
The phage model
The model developed here is an extension of that in [28]. There
are four populations of bacteria. Two are sensitive to the phage, N,
non–CRISPR and C, CRISPR and two that are either fully
resistant (envelope resistance), or immune because of CRISPR, NR
and CR, respectively. The variables N, C, NR and CR are the both
the densities (bacteria per ml) of these populations and used as
their designations. There is one population of phage, with density
and designation, P particles per ml.
The phage adsorb to the N and C and CR bacteria with rate
constants, dN and dC (ml per phage per cell per hour) respectively.
Phage do not adsorb to bacteria with envelope resistant, i.e. the NR
cells. To account for a possible multiplicity of infection (MOI)
effect on survival of phage-infected CR, the effective killing rate
constant for phage adsorption to CRISPR can be an increasing
function of the ratio of free phage and CR cells, M=P/CR.
dCR(M)~dMINzx
dMAXMn
qzMn ð1Þ
where dMIN and dMAX are the minimum and maximum
adsorption rates. The parameter x is a coefficient (0#x#1) that
specifies the magnitude of the MOI effect, q is the MOI where the
adsorption rate is half its maximum value and n is an exponent
which contributes to the shape of the distribution. At low
multiplicities, dCR (M) the CRISPR cells would be effectively
immune (resistant) (Figure 1). At high multiplicities, however,
immune CRISPR cells can be overburdened by phage, their
immunity would be overridden, and the phage would replicate,
killing the cells. On the other side, we assume that the phage are
removed from the population by adsorption to immune CRISPR
cells at the maximum adsorption rate, dMAX.
For convenience I neglect the latent periods of the phage infection
but assume that the phage have potentially different burst sizes, bN,
bC,a n dbCR particles per cell, for N, C and CR cells, respectively.
Phage-immune CRISPR cells, CR are produced from C at a rate
proportional to the rate at which the phage adsorb to them and a
Author Summary
CRISPR is the acronym for the adaptive immune system
that has been found in almost all archaebacteria and
nearly half the eubacteria examined. Unlike the other
defenses bacteria have for protection from phage and
other deleterious DNAs, CRISPR has the virtues of
specificity, memory, and the capacity to abort infections
with a virtually indefinite diversity of deleterious DNAs. In
this report, mathematical models of the population
dynamics of bacteria, phage, and plasmids are used to
determine the conditions under which CRISPR can become
established and will be maintained in bacterial populations
and the contribution of this adaptive immune system to
the ecology and (co)evolution of bacteria and bacterio-
phage. The models predict realistic and broad conditions
under which bacteria bearing CRISPR regions can invade
and be maintained in populations of higher fitness
bacteria confronted with bacteriophage and narrower
conditions when the confrontation is with competitors
carrying conjugative plasmids. The models predict that
CRISPR can facilitate long-term co-evolutionary arms races
between phage and bacteria and between phage- rather
than resource-limited bacterial communities. The param-
eters of these models can be independently estimated, the
assumptions behind their construction validated, and the
hypotheses generated from the analysis of their properties
tested with experimental populations of bacteria.
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will be aborted and a CRISPR strain will be produced. At a rate v
per cell per hour, CRISPR lose their immunity, CRRC. For the N
and C populations the loss of the adsorbed phage is subsumed in the
value of the burst size (which is one less than the number of phage
produced). For the CR population, the loss of the phage due to
adsorption is specifically considered because only a small fraction of
the adsorbed phage replicate when the MOI is low.
In Table 1, I separately define these parameters and in Figure 2,
illustrate the interactions between the different populations of
bacteria and the phage. The equations for this model follow.
dR
dt
~w(A{R){(VNNzVCCzVNRNRzVCRCR)
eR
(Rzk)
dN
dt
~NyN(R){dNNP{mN{wN
dC
dt
~CyC(R){dCCPznCR{wC
dCR
dt
~CRyCR(R){dCR(M)CRPzmdCPC{nCR{wCR
dNR
dt
~NRyNR(R)zmN{wNR
dP
dt
~dNNbNPzdCC(bC{1)P(1{m)zdCR(M)CRbCRP
{dMAXCRP{wP
The conjugative plasmid model
The model developed here is an extension of that in [29]. There
are five bacterial populations. Two populations do not code for
CRISPR, N and NP, and three populations code for CRISPR, C
and CP and CX. The NP and CP populations bear the conjugative
plasmid and CX, carries CRISPR and plasmid sequences that
make it completely immune to the receipt of these plasmids.
Plasmids are transferred by conjugation at rates proportional to
the product of the densities of the plasmid-bearing and plasmid-
free populations and rate constants, cNN, cNC, cCN and cCC (ml per
cell per hour) respectively for the transfer of the plasmid from NP
to N, NP to C, CP to N and CP to C., respectively. Plasmids are lost
by vegetative segregation at rates tN and tC per cell per hour, with
NPRN and CpRC. C are converted to CX at a rate proportional to
the rate at which C acquires the plasmid and a probability m
(0#m#1). Cx lose the CRISPR plasmid immunity region and
become C at rate n per cell per hour. Each of the cell lines, have a
maximum growth rate, VN, VNP, VC, and VCP, and VX per hour. In
Figure 3, I illustrate the interactions between the different cell lines
in this model, and, in Table 2, I separately define the parameters
and variables. The equations for this model are:
dR
dt
~w(A{R){(VNNzVNPNPzVCCzVCPCCPzVxCx)
eR
(Rzk)
dN
dt
~yN(R)N{cNNNPN{cCNNCPztNNPzzCzzCX{wN
dNP
dt
~yNP(R)NPzcNNNPNzcCNNCP{tNNPzzCP{wNP
dC
dt
~yC(R)C{cNCNPC{cCCCPCztCCPznCX{zC{wC
dCP
dt
~yCP(R)CPzcNCNPC(1{m)zcCCCPC(1{m){tCCP
{zCP{wCP
dCX
dt
~yX(R)CXzcNCNPCmzcCCCPCm{nCX{zCX{wCX
Numerical solutions
For the numerical solutions to these equations (computer
simulations) I use a differential equation-solving software package,
Berkeley Madonna. For the phage simulations there is a refuge
density, below which the phage are unable to adsorb to the bacteria.
The purpose of this is to control the system from oscillating without
limits, see [30]. In these simulations, if the phage density falls below
10
21 particles per ml, the phage are considered to be lost. Copies of
these simulations are available online, www.eclf.net/programs.
Results
The population dynamics and evolution of CRISPR
bacteria with phage
The bacterial growth, resource-uptake, phage adsorption
parameters and burst sizes used in these simulations (Table 1)
are in a range similar to that which we observed for E. coli and the
phages T2 and T7 [28,31].
Invasion and maintenance of CRISPR in the absence of
envelope resistance. In a chemostat with susceptible bacteria
at an equilibrium density N*, a lytic phage can become established
and will maintain a population with sensitive bacteria as long as
the rate of phage production exceeds the rate of washout,
dNbNN*.w [28]. With the parameters used in these simulations,
N
*,10
8 (see [32]). As long as dNbNN
*.2610
29, the phage will
become established and can maintain a population by replicating
on sensitive bacteria (Figure 4A). The oscillations in the densities of
bacteria and phage in these and the following simulations are those
anticipated for the predator-prey nature of these dynamics.
To explore the conditions under which a CRISPR population
will become established and be maintained in the presence of
phage, I consider situations where the C and CR populations have
an intrinsic selective disadvantage relative to N (VN.VC, VCR) and
therefore cannot invade an established N population in the
absence of these bacterial viruses. Because of the immunity of CR,
with phage present and in the absence of a multiplicity effect, an
initially rare CRISPR population will invade and ascend to
dominance despite its lower intrinsic fitness (Figure 4B). With these
parameters, the phage are maintained along with N and C, the
latter being continually generated by the loss of immunity by the
dominant CR population. The N population is maintained because
of its higher intrinsic fitness (growth rate) relative to CR, and
resources, rather than phage predation, limit the bacteria at large.
The phage continue to be maintained by replicating on the N and
C cells. Although the oscillations are damped and in time would
no longer be noticed, that time would be considerably greater than
would be feasible to study experimentally with chemostats. If we
allow for a strong multiplicity effect (x=0.5), the CRISPR
population becomes established, and both immune and non-
immune CRISPR cells maintain their populations with sensitive
non–CRISPR in a phage- rather than resource- limited commu-
nity (Figure 4C). When the magnitude of the multiplicity effect is
reduced (x=0.2), the phage continue to be maintained but
immune CRISPR cells ascend to dominance and the community
with three populations of bacteria, N, C and CR are maintained in
a resource- rather than a phage-limited state (Figure 4D).
The invasion and maintenance of CRISPR in the presence
of envelope resistance. In addition to CRISPR immunity,
when confronted with phage, bacteria may generate mutants to
which phage are unable to adsorb or are resistant by other
mechanisms [33]. To explore how this envelope resistance will
affect the conditions for the establishment and maintenance of
CRISPR, we consider the invasion of an envelope resistant strain
of N, NR, into a population of N and phage. In these simulations,
Conditions for the Existence of CRISPR
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than C and CR,( VNR,VC, VCR). Were the NR cells more fit than C
and CR, they would dominate and the CRISPR population would
not invade an would not be established. Whether this fitness
relationship will be seen with real bacteria and what those fitness
will be is an empirical question.
Figure 1. Adsorption rate as a function of the multiplicity of infection (MOI), dMIN=10
214, dMAX=5 610
29, x=0.5, or x=0.2 q=10
2,
and n=2.
doi:10.1371/journal.pgen.1001171.g001
Table 1. Phage model variables and parameters.
Variable* or Parameter+ Definition Parameter Definition
N P Sensitive N-C w Dilution rate
NR P Resistant N-C dN Adsorption rate P to N
C P Sensitive C dC Adsorption rate P to C
CR P Immune C dMIN Min. Adsorp. Rate P to CR
P Phage dMAX Max. Adsorp. rate P to CR
R Resource Conc. x Multiplicity Coef. P to CR
VN Max. Growth N n Multiplicity Exp. P to CR
VNR Max. Growth NR q Multiplicity half Max Density
VC Max. Growth C bN Bursts size P on N
VCR Max. Growth CR bC Burst size P on C
K Monod Constant bCR Burst size P on CR
E Conversion Effic. m Mutation rate N to NR
A Reservoir Conc. R m Fraction of infected CRCR
v Rate of Loss of immunity CRRC
N-C – Non CRISPR, C – CRISPR.
*The variables are densities of bacteria or phage per ml or the concentration of the resource, mg per ml.
+See the text for the dimensions of the parameters.
doi:10.1371/journal.pgen.1001171.t001
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the least intrinsically fit bacteria in the community (lowest
maximum growth rate), in the presence of phage it ascends
rapidly and achieves dominance. During this initial phase, as a
consequence of the production of immune CR cells, the CRISPR
population also increases in density, but remains a minority
population relative to the resistant non–CRISPR NR. With these
parameters, the phage density declines after the ascent of
resistance and the densities of both the N and C populations
increase. Shortly after the phage are eliminated the highest fitness
N population ascends and lower fitness C, CR and NR decline. If the
phage resistant population is substantially less fit than the other
bacterial populations, the CR population ascends to dominance
and continues to co-exist with the phage, N, and C populations
(Figure 5B).
The population dynamics of CRISPR with conjugative
plasmids
In accord with [34], conjugative plasmids will be maintained as
long as the rate of infectious transfer exceeds the rates of loss of the
plasmid due to selection against the cells carrying it, vegetative
segregation, and the rate of flow through the chemostat. In terms
of the above parameters, the plasmid will be maintained in an N-
NP population as long as
cNNw
(VN{VNP)
VN
wztN
N  ð2Þ
where N
* is the density of plasmid-free cells at the chemostat
equilibrium. For example, if VN=1.0, VNP=0.95, w=0.2,
tN=10
23, the plasmid will be maintained in a population of
density N
*=10
8 as long as cNN.1.1610
210. If the plasmid
augments the growth rate (which in this model is the sole
parameter of cell fitness) of the bacteria that carry it, VNP.VN,a s
we would anticipate for antibiotic resistance encoding plasmids in
the presence of the selecting antibiotic, bacteria bearing the
plasmid will be able to invade even without transfer, as long as the
segregation rate, tN, is sufficiently small.
Invasion and maintenance of CRISPR in the presence of a
competing population bearing a conjugative plasmid. The
population dynamics of selection and plasmid transfer in an
equilibrium chemostat in the absence of CRISPR are presented in
Figure 2. Model of the population dynamics of lytic phage with CRISPR-mediated adaptive immunity and envelope resistance in
continuous culture: P – phage, N – phage sensitive non–CRISPR bacteria, NR – envelope resistant, non–CRISPR bacteria C - phage
sensitive CRISPR bacteria, CR - phage immune CRISPR bacteria. The ds are the adsorption rate constants, m is the fraction of C to which
phage are adsorbed that enter the immune state, n is the rate at which immune CRISPR cells lose their immunity, and m is the rate of mutation to
envelope resistance. While the phage adsorb to immune CRISPR cells at the maximum rate and are removed from the phage population, their
replication on CRISPR cells and the rate of mortality of immune CRISPR is either 0 or a monotonically increasing function of the multiplicity of
infection (equation (1)). The bacteria reproduce at a rate proportional to the concentration of a limiting resource and their maximum rates of
replication. Phage replication is through the killing of adsorbed bacteria and their burst size, b, on that cell line. The limiting resource in the reservoir
is at concentration A mg/ml and enters the vessel at a rate, w, which is the same rate at which the phage and bacterial populations and excess
resource, R, are removed from the vessel. For more details see the text.
doi:10.1371/journal.pgen.1001171.g002
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PLoS Genetics | www.plosgenetics.org 5 October 2010 | Volume 6 | Issue 10 | e1001171Figure 3. Model of the population dynamics of a conjugative plasmid with CRISPR-mediated adaptive immunity in continuous
culture. N - plasmid-free non–CRISPR, NP - plasmid-bearing non–CRISPR, C - plasmid-free CRISPR, CP - plasmid-bearing CRISPR, CX - immune CRISPR.
The cs are the rate constants of plasmid transfer, m is the fraction of CP that enter the immune state CX upon receiving the plasmid from an NP or CP,
n is the rate at which immune CRISPR cells lose their immunity and z the rate at which the CRISPR cells lose the CRISPR element and become N or NP.
The bacteria reproduce at a rate proportional to the concentration of a limiting resource and their maximum rates of replication. The limiting
resource in the reservoir is at concentration A mg/ml and enters the vessel at the rate, w, which is the same as the rate at which the phage and
bacterial populations and excess resource, R, are removed from the vessel. For more details see the text.
doi:10.1371/journal.pgen.1001171.g003
Table 2. Plasmid model variables and parameters.
Variable* or Parameter
+ Definition Parameter Definition
N Plasmid-free N-C e Conversion efficiency
NP Plasmid-bearing N-C cNN Pl rate constant NP to N
C Plasmid-free C cNC Pl rate constant NP to C
CP Plasmid-bearing C cCN Pl rate constant CP to N
CX Immune C cCC Pl rate constant CP to C
R Resource Conc. tN, Pl Segreg. Rate NP to N
VN Max. Growth N tC Pl Segreg. Rate CP to C
VNP Max. Growth NP u Rate of loss of Immunity CX to C
VC Max. Growth C m Fraction of infected C become CX
VCX Max. Growth CP w Dilution rate
VX Max. Growth X A Resource Conc. Reservoir
k Monod Constant z Rate of loss of CRISPR into N or NP
N-C Non–CRISPR, C- CRISPR.
*Variables are bacteria per ml or for the resource mg/ml.
+See the text for the dimensions of the parameters.
doi:10.1371/journal.pgen.1001171.t002
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plasmid- bearing cells become established and ascend to dominate
the N-NP community, whether cells bearing the plasmid are
favored or not. If the plasmid is maintained by transfer or selection
for the genes it carries and tN.0, there will be a stable population
of plasmid-free cells. When the rate constant of plasmid transfer is
too low, the deleterious plasmid will be lost.
To consider the effects of CRISPR on the population dynamics
of bacteria with conjugative plasmids and the conditions under
which CRISPR immunity will provide an advantage to bacteria, I
let the maximum growth rates of the CRISPR strains (the sole
measure of intrinsic, phage-independent fitness) be somewhat
lower than the corresponding non–CRISPR cells. In Figure 6B,
the population is initially at equilibrium with a plasmid-free, non-
immune CRISPR population and a low density of plasmid-
bearing non–CRISPR bacteria are introduced. The plasmid
spreads rapidly from NP to C producing a CP population which
in turn generates immune CRISPR, CX. While the C and CP
populations die out, CX ascends to dominance and minority
populations of N and NP are maintained. Although the CX
population has a lower growth rate than N, in the presence of a
deleterious conjugative plasmid they have an advantage because
they cannot be infected by that element. They do not eliminate the
N and NP populations due to the loss of the CRISPR region and
the conversion into N. As can be seen in Figure 6C, with these
parameters and a lower growth rate, CX can invade an equilibrium
N-NP population, but the rate of increase in the density of Cx is
low. The invasion rate for CX would even be further reduced if,
instead of CX, a plasmid-free C invaded an NP population,
because it would be some time before the CX is produced and, in a
finite population, may not be produced at all (‘‘data’’ not shown).
A very different situation obtains when the plasmid confers a
growth rate advantage to the infected host (Figure 6D). Under
these conditions, the C populations and its derivatives, CP and CX,
are eliminated.
Discussion
‘‘All models are wrong, some are useful.’’ (George Box)
It has been less than eight years since the ubiquitous clusters of
palindromic repeats now known as CRISPR first acquired this
moniker [35]. Although there had been compelling circumstantial
Figure 4. Population dynamics of lytic phage, P, with sensitive non–CRISPR bacteria, N, non-immune and immune CRISPR-encoding
cells, C and CR, respectively. Changes in the densities of the bacterial and phage populations and the concentration of the limiting resource, R. In
this and the other simulations, A=50 mg/m, w=0.2 per hour, e=5610
27mg, k=0.25 mg. In these phage simulations, bN=bC=bCP. (a) The dynamics
of sensitive bacteria and phage in the absence of CRISPR, VN=1.0 hr
21, dN=5 610
29. (b) Invasion of CRISPR in the presence of phage, no MOI effect
(x=0), VN=1.0. VC=0.95, VCR=0.90, dN=dC=5 610
29, dCP=dMIN=10
214 (dMAX=5 610
29) (c) Invasion of CRISPR with presence of phage VN=1.0.
VC=0.95, VCR=0.90, dN=dC=5 610
29, Strong MOI effect (x=0.5, n=2.0, q=10
2, dMIN=10
214, dMAX=5 610
29). (d) Invasion of CRISPR with presence of
phage, VN=1.0. VC=0.95, VCR=0.90, dN=dC=5 610
29, Modest MOI effect (x=0.2, n=2.0, q=10
2, dMIN=10
214, dMAX=5 610
29).
doi:10.1371/journal.pgen.1001171.g004
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that provides protection against infecting phage and plasmids, it
has been less than four and three years respectively since the
publication of the first direct (read experimental) evidence that
CRISPR can provide immunity to infection by lytic phage [17]
and conjugative plasmids [18].
In the course of this time a great deal has been learned about
the molecular biology of CRISPR and the mechanisms by which it
provides adaptive immunity to plasmid and phage infection. But
there remain many unanswered questions about these processes.
Most important for this consideration is a dearth of the
quantitative information needed to understand the population
dynamics of CRISPR-mediated adaptive immunity and thereby
the conditions for the establishment and maintenance of CRISPR
in bacterial populations. To my knowledge, this study is the first
formal consideration of these dynamics.
The models
The models developed in this report incorporate what has been
learned about CRISPR-mediated adaptive immunity to phage
and conjugative plasmids, primarily from the studies of
Barrangou and colleagues [17] and Marraffini and Sontheimer
[18], into models of the population dynamics of lytic phage [28]
and conjugative plasmids [29]. Although they may appear
complex, at best they are simplistic caricatures of interactions
between these infectious genetic elements and bacteria with
CRISPR-mediated adaptive immunity. These models are not
intended or anticipated to be numerically precise analogs of these
processes and dynamics.
The role of these mathematical models is similar to that of the
diagrammatic models (cartoons) used to illustrate the molecular
basis and mode of action of CRISPR, i.e., to provide a framework
for understanding these processes, designing experiments, and
interpreting their results. In this case, these experiments are on
population and evolutionary dynamics of bacteria with CRISPR-
mediated immunity confronted with lytic phage and competing
bacteria bearing conjugative plasmids. The purpose of these
models for this experimental enterprise is: (i) to identify and, in a
quantitative way, evaluate the role of the different factors
(parameters) contributing to these dynamics and the conditions
for the establishment and maintenance of CRISPR in bacterial
populations, and (ii) to generate hypotheses about these dynamics
and existence conditions that can be tested (and rejected) in
experimental populations.
Figure 5. Population dynamics of lytic phage, P, with sensitive and resistant non–CRISPR bacteria, N and NR, non-immune and
immune CRISPR-encoding cells, C and CR, respectively. Changes in the densities of the bacterial and phage populations and the
concentration of the limiting resource, R. Unless otherwise noted, the parameter values used are those in Figure 4B. (a) Invasion of C and NR into a
population with phage, modest cost of resistance, VNR=0.85. (b) Invasion of C and NR into a population with phage, with a greater cost of resistance,
VNR=0.70.
doi:10.1371/journal.pgen.1001171.g005
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The results of the analysis of the properties of the phage -
CRISPR model are consistent with the proposition that in the
presence of lytic bateriophage there are broad conditions under
which a CRISPR–like adaptive immune system can become
established and will be maintained in bacterial populations. With
population densities, growth rates, and phage infection parameters
in realistic ranges, these models predict that despite a growth rate
disadvantage, bacteria with CRISPR–like acquired immunity to
infecting phage will increase in frequency when initially rare and
will be maintained. The necessary condition for this is that the
phage population continues to persist at a sufficiently high density
for CRISPR-mediated adaptive immunity to overcome an
intrinsic disadvantage associated with the costs of carrying and
expressing these genes.
When will the phage maintain their populations at sufficient
levels for this outcome? With the parameters used to address this
question, the phage will be maintained under broad conditions,
but may eventually be lost if a population with envelope or other
resistance ascends to dominance. I emphasized the word may for
two reasons. The first is theoretical, if the relative growth rate of
the resistant population is adequately low, the phage and thereby
CRISPR will be maintained. The second is empirical, even when
resistant bacteria dominate experimental populations of bacteria
and phage, in general the phage continue to be maintained
[30,31,36].
The CRISPR plasmid model predicts that because of the
immunity to infection with conjugative plasmids, a lower growth
rate (Malthusian fitness) CRISPR population can become
established and will be maintained when competing with bacteria
with a greater Malthusian fitness but bearing deleterious (fitness-
reducing) conjugative plasmids. Although these conditions are met
with plasmid fitness costs in the range estimated for ‘‘laboratory’’
plasmids [9,37], it is not clear that naturally occurring plasmids
would be as burdensome as those maintained in the Lab. The
greater the Malthusian fitness burden attributed to the plasmid,
the greater the advantage of CRISPR-mediated immunity.
The rate constants of plasmid transfer used in these simulations
are those for plasmids with permanently derepressed conjugative
pili synthesis. Wild type conjugative plasmids are more likely to be
repressed for the production of these transfer organelles and would
have substantially lower rates of transmission than plasmids that
Figure 6. Population dynamics of a conjugative plasmid with non–CRISPR, N and NP and CRISPR, C, CP and CX populations; changes
in the densities of the bacterial populations. Unless otherwise noted all of the rate constants of plasmid transfer, the cijs=10
29 [38], the
segregation rates, tN and tC=10
23, the rate of loss of immunity n=10
23, upon receiving the plasmid the rate of conversion of CP to CX=0.2, and the
rate of conversion of CRISPR cells to N or NP,z=1 0
28. (a) No CRISPR – Just N and NP 1 - Deleterious plasmid VN=1,V NP=0.95; 2 - a beneficial plasmid
VN=1,V NP=1.2 and 3- deleterious plasmid VN=1,V NP=0.95, cNN=10
211. (b) Invasion of bacteria carrying a deleterious plasmid into a lower fitness
CRISPR, C, population, VN=1,V NP=0.95, VC=0.97, VCP=0.88, Vx=0.96, (c) Invasion of CRISPR X into a equilibrium population of plasmid-bearing and
plasmid free cells, N-NP with a deleterious plasmid (parameters the same as b). (d) Invasion of cells carrying a higher fitness plasmid, NP, into a C
population, VN=1,V NP=1.2 VC=0.97, VCP=1.1, Vx=0.96.
doi:10.1371/journal.pgen.1001171.g006
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it is not clear whether in natural populations conjugative plasmids
that engender fitness cost can be maintained by transfer alone.
Their persistence may require periodic episodes where bacteria
carrying them have an advantage [34,40], but also see [41]. If the
rate of infectious transfer is not sufficient to maintain deleterious
plasmid in a population and they persist by continually or
periodically enhancing the cells Malthusian fitness, immunity to
these plasmids would not be sufficient to maintain CRISPR-
encoding cells that have an intrinsic fitness disadvantage.
Evaluating the models: estimating their parameters and
testing the validity of their assumptions and predictions
It would be nearly impossible to determine whether the
quantitative conditions predicted by these models for the
establishment and maintenance of CRISPR-mediated immunity
are met in natural populations. On the other hand, the values of
the parameters of these models can be estimated and the validity of
the assumptions behind their construction and hypotheses
generated from the analysis of their properties can be tested in
laboratory culture using CRISPR–positive and CRISPR–negative
bacterial constructs, phage and plasmids of the types used
respectively by Barrangou and colleagues [17] and Marraffini
and Sontheimer, [18] in chemostat culture.
Parameters. All of the parameters of these models (Table 1
and Table 2) can be independently estimated and procedures for
doing so have been published for the majority of them: (1) for the
bacterial growth and resource utilization parameters, the VS, k,
and e, see [26,28]; (2) for the phage latent periods, adsorption rates
ds, and burst sizes, the bs, see [28], (3) for the rate constants of
plasmid transfer, the cs, see [42,43], and (4) for the mutation rate
to envelope resistance, see [44,45]. Estimates of the plasmid
segregation rate, t, can be obtained by plating low-density cultures
of plasmid-bearing cells, and testing colonies for the plasmid
marker. However, unless t is very high (t.0.005 per cell per
division), this procedure would be excessively labor intensive.
However, if low, this parameter would have a negligible
contribution to the dynamics of the plasmid and estimating its
value would not be worthwhile.
Protocols for isolating bacteria with CRISPR-mediated resis-
tance to phage and plasmid infection, can be found in [17] and
[18], respectively. I am, however, unaware of published studies
providing estimates of the fractions of phage and plasmid infected
cells that become immune, the parameter m, or the rates of loss of
these immunities, n, in the models (Figure 2 and Figure 3). In Text
S1, I outline potential ways to estimate these parameters. I
emphasize the word potential because without actually doing these
experiments, it is difficult to anticipate pitfalls and problems with
the proposed procedures.
Assumptions and tests of their validity. In developing the
model, I made a series of assumptions about CRISPR – mediated
immunity and the population dynamics of bacteria with lytic
phage and conjugative plasmids. In the following, I list these
assumptions and briefly describe what would be anticipated
experimentally if these assumptions are correct.
(i) CRISPR immunity to phage infection will have no effect
on the rate at which phage adsorb to immune cells. If this is
correct, the estimated adsorption rate parameter d of a lytic
phage should be the same for CRISPR cells of any
immune state as well as cells of that strain for which
CRISPR is non-functional.
(ii) Phage infecting immune CRISPR cells will be lost. If this is
correct, when low densities of phage are introduced into
relatively high densities of exponentially growing popula-
tions of immune CRISPR cells, there should be a decline
rather than an increase in the density of phage. In the
model, the rate of decline in the density of phage, P,
adsorbing to a population of bacteria with CRISPR
immunity to that phage can be calculated from the
estimated adsorption maximum rate parameter dMAX and
the density and maximum growth rate of bacteria, CR and
VR, respectively.
dP
dt
~{dMAXCR
dCR
dt
~VRCR
If as suggested in [17], the level of CRISPR – mediated
immunity to the phage varies with the extent and nature of
the phage DNA incorporated into the CRISPR region, this
should be reflected as variation in the rate of loss of the
phage.
(iii) There is a multiplicity of infection (MOI) effect. When
CRISPR-encoding cells are confronted with high multi-
plicities of phage to which they are immune, the phage will
replicate and kill the immune cells. If positive results are
obtained in these MOI experiments, by varying the
multiplicity, the functional relationship between the MOI
and the level of immunity can be determined. In doing
these experiments, however, it will be necessary to rule out
the possibility that those that phage that replicate on
immune cells are not host range mutants [24].
(iv) CRISPR immunity to conjugative plasmid transfer is
absolute. If this is correct, the estimated rate constant of
plasmid transfer c for mixtures of donor CRISPR cells
immune to that plasmid would be zero independent of the
density of the culture and ratio of donors and potential
CRISPR recipients. Based on the results reported in [18]
as well as [17], it may well be that the level of CRISPR –
mediated immunity to plasmid infection as measured by
the rate constant of plasmid transfer, dx, would vary with
the extent and nature of plasmid DNA incorporated into
the CRISPR region.
(v) CRISPR immunity to plasmid infection is generated
during the transfer process, when the recipient first receives
the plasmid, rather than during the course of plasmid
carriage. If this the case, bacteria immune to plasmid
transfer, CX, would be rare in cultures of plasmid-bearing
CRISPR, the CP population. That is, they would only be
generated, when CP transfer the plasmid to segregants, C.
Population dynamics and existence conditions
predictions. One way to evaluate how well these models
serve as analogs of the population dynamics of bacteria with
CRISPR adaptive immunity to bacteria and phage is to compare
the results of simulations with independently estimated parameters
to that observed in chemostat populations. Although it would be
gratifying to see quantitative agreement between the anticipated
dynamics and those observed in experimental populations,
populations with CRISPR constructs of bacteria, conjugative
plasmids and phage, it would also be surprising. These models are
far too simple to expect the predicted and observed dynamics to be
numerically coincident. A more modest, realistic, and, I believe,
more useful goal is test predictions made from the analysis of the
properties of these models in a qualitative – semi-quantitative way
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to make the models more realistic and accurate. In the following, I
list these predictions.
The phage model. (i) When mixtures of otherwise isogenic
CRISPR positive and negative phage –sensitive constructs are
introduced into chemostats in approximately equal frequencies:
(a) CRISPR cells with immunity to the phage will emerge and
ascend to dominance.
(b) If the phage are maintained, the CRISPR population will
continue to persist.
(c) If non–CRISPR mutants with envelope or other resistance
to the phage evolve, or are introduced, unless they have a
considerable cost in Malthusian fitness, these resistant
bacteria will increase in frequency and may replace the
CRISPR population.
(d) Although not considered in the model, there is the possibility
that CRISPR cells C or CR will acquire envelope resistance.
If so, a CRISPR population with envelope resistance may
dominate.
(ii) When introduced at low frequencies into chemostats with
sensitive non–CRISPR cells in the presence of phage, as long as
immune CRISPR cells are produced, the CRISPR population will
increase in frequency. This will not be the case in the absence of
phage.
The plasmid model. When mixtures of non–CRISPR cells
bearing fitness reducing conjugative plasmids and plasmid-free
CRISPR cells are introduced into chemostats:
(a) CRISPR cells with immunity to the plasmid will emerge.
(b) the immune CRISPR population will increase in frequency,
even if the CRISPR cells have lower growth rates than
plasmid-free non–CRISPR.
(c) the CRISPR population will decline in frequency if the
environmental conditions changed so that selection favors
cells bearing the plasmid. (One way to do this experiment is
to use antibiotic resistance, R- plasmids and periodically add
antibiotics to which the plasmid confers resistance).
Caveats, excuses, recognized limitations, extensions, and
speculations
In this report, I elected to restrict the model and its analysis to
the simplest cases with lowest realistic number of states of bacteria,
phage and plasmids. I have done so because at this time these
minimum number of states models and the predictions generated
from their analysis are more amenable to evaluating and testing
experimentally than models with more states of bacteria, phage
and plasmids. Moreover, these tests, and particularly the
population dynamic experiments, should indicate the importance
of the generation of additional population states by mutation, like
host range phage and host range plasmids, are to these dynamics.
Be that as it may, I also realize that this minimum number of states
model will not account for what may turn out to be the most
important contributions of CRISPR-mediated immunity to the
ecology as well as the population and evolutionary biology of
bacteria and phage.
Generalized resistance. Luciano Marraffini (personal
communication) suggested one potentially important contribution
ofCRISPRtothe populationandevolutionarydynamicsofbacteria
and phage. Unlike envelope resistance, which is almost always
restricted to phage that utilize single adsorption organelles, [33],
CRISPR–immunity can be effective against multiple phages with
different adsorption organelles (independent resistance). Moreover,
envelope resistance is likely to engender a cost in Malthusian fitness,
e.g. see [31,36,46] and that cost will almost certainly be greater if
this resistance is for multiple phages that employ different receptors
for infection.
If these interpretations are correct, it would seem experimental
populations with CRISPR-encoding bacteria with envelope
resistance to all the phage will not evolve and CRISPR will
prevail in competition with sensitive non–CRISPR cells. If,
however, the results of a test of this multi-phage hypothesis
Ryzard Koroana and did in a study of the conditions for the
maintenance of restriction endonuclease (restriction-modification,
R-M) immunity are general [47], this hypothesis may be rejected.
E. coli bearing an R-M system conferring immunity to three phage
with different organelles were challenged with a mixture of all
three of these phages. As a consequence of a hierarchy of phage
replication [48], there was sequential selection for the different
resistant states and within a day of exposure, bacteria with
envelope resistance to all three phages dominated the community
[47].
A CRISPR-mediated arms race and phage-limited
communities. A number of years ago, Richard Lenski and I
postulated that the arms race between bacterial resistance and host
range phage would be limited to few cycles and is likely to end with
resistant bacteria to which phage would not be able to generate
host range mutations [46]. The empirical basis of our hypothesis
was the results of experiments with E. coli and its phage and
envelope resistance, [31,46,49,50]. While this interpretation was
also supported by experiments with V. cholerae and its phage JSF4
[36], experiments with Pseudomonas fluorescens and its phage SBW25
[51] suggest extended arms races are possible. Although, to my
knowledge, the mechanisms responsible for the continuous
changes in resistance and host-range reported in this study with
this strain of Pseudomonas and phage have yet to be elucidated,
CRISPR does provide a mechanism for long-term arms races
between bacteria and phage [21,22,24]. By single base changes in
sequences of DNA into the spacer regions of CRISPR, a phage
can infect and replicate on previously immune CRISPR cells. By
incorporating the mutated or other region of that phage into
another spacer, CRISPR cells can generate resistance to these host
range phages. At this time, it is not at all clear how long or through
how many cycles a CRISPR-mediated arms race can proceed. I
would it certainly be interesting, tenable experimentally and fun to
find out. Be it by CRISPR or by sequential resistance and host-
range mutation [52,53] an extended arms race could provide a
way for phage, rather than resources, to limit the densities of
bacterial populations (see Text S2), which is an ecological outcome
with practical as well as theoretical implications, e.g. see [54–59].
Supporting Information
Text S1 Protocols to estimate the probability of formation, m,
and rate of loss, n, of CRISPR-mediated immunity to phage and
conjugative plasmids.
Found at: doi:10.1371/journal.pgen.1001171.s001 (0.03 MB
DOC)
Text S2 Arms races and phage-limited bacterial populations.
Found at: doi:10.1371/journal.pgen.1001171.s002 (0.33 MB
DOC)
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